The JRC is offering a position in the field of immunological safety testing of nanomaterials.


The JRC Exploratory Research Programme (ER) is a strategic initiative characterised by ideas that may lead to novel results, which are going to qualitatively enrich the current scientific work at the JRC.

The vacancy is within the Directorate Health, Consumers and Reference Materials. The directorate provides independent scientific evidence for the development, implementation and evaluation of EU policies, mainly in the areas of standardisation, public health, food and feed safety and authenticity, cosmetics and other consumer products, medical devices, nanomaterials, taxation with a focus on frauds and a well-functioning internal market.

The operational scientific research will take place in the unit Consumer Products Safety.

FG IV – Project Officer Exploratory Research Project: Personalised Immunological Risk Assessment Technologies (PIRAT) (PDF, 0.2 MB)

For more information please see

Events where you meet EUNCL

More Events ...

European Nanomedicine Characterisation Laboratory (EUNCL)

Call for Proposals!


  • NCI-NCL – Open position
    The NCL is looking for an experienced analytical chemist to add to our team.
  • EUNCL ExBo Meeting in Liverpool
    The EUNCL ExBo met on 22nd and 23rd November 2018 at University of Liverpool to discuss the actual status of the work in the project and especially in the TNA. The CET and TNA management updated the ExBo on the on-going and the further work planned. The discussion on all questions raised during the meeting was very extensive and important decisions were taken for the last year of the project duration.
  • CLINAM 2018 with EUNCL Participation
    It was the 11th Summit of its kind. CLINAM again welcomed the participants from the community of nanomedicine, targeted drug delivery and precision medicine and bring together the pioneers and worldwide opinion leaders, not only to learn and discuss but also to develop new ideas, create new collaborative projects and shape the future of medicine.

More News ...